Skip to main content
. 2017 Jan 11;2017(1):CD001284. doi: 10.1002/14651858.CD001284.pub2

Rodrigo 1995.

Methods ‐ Prospective, randomised, double‐blind study.
‐ Comparison of ipratropium bromide and salbutamol vs. salbutamol alone.
‐ Method of randomisation unclear.
‐ No information on allocation concealment provided.
Participants ‐ Patients presenting to the ED with an exacerbation of asthma with an FEV and PEF ≤ 50% of predicted value.
‐ Set in Uruguay.
‐ Ages: 18 to 50 years.
‐ Asthma exacerbation severity of presenting patients was unclear. Insufficient information presented.
Interventions ‐ Multiple doses of combination inhaled therapy. Study interventions provided via MDI spacer.
‐ Group one received four puffs of ipratropium bromide (20 μg/puff) and salbutamol (100 μg/puff) every 10 minutes for 3 hours.
‐ Group two received four puffs of salbutamol (100 μg/puff) along with placebo (propellant) every 10 minutes for 3 hours.
‐ Additional co‐interventions provided in the ED included IV hydrocortisone (500 mg) after upon completion of initial treatment for all patients.
Outcomes ‐ Outcomes included pulmonary function and adverse events.
‐ Outcome measurements were performed at baseline, as well as 30, 60, 90, 120, 150, and 180 minutes after the start of treatment.
Notes ‐ Contacted authors for additional information but no response received.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomised but no information provided.
Quote (p. 177): "Los sujetos fueron asignados aleatoriamente a uno de dos grupos de tratamiento." (T ranslation: "Subjects were randomly assigned to one of two treatment groups").
Allocation concealment (selection bias) Unclear risk No information provided on allocation concealment.
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Double blinded but no information was provided.
Quote (p. 177): "Se utilizaron procedimiento de tipo doble ciego." (Translation: "We used double‐blind procedures.")
Blinding of outcome assessment (detection bias) 
 All outcomes Unclear risk No information provided on whether outcome assessors were blinded.
Incomplete outcome data (attrition bias) 
 All outcomes Unclear risk Unclear how many patients were screened, refused or excluded.
Selective reporting (reporting bias) Unclear risk No protocol available.
Other bias Unclear risk No source of funding provided.